Eliem Therapeutics Inc (ELYM)

NASDAQ
15.81
+0.58(+3.81%)
After Hours
15.81
0.00(0.00%)
- Real-time Data
  • Volume:
    103,100
  • Bid/Ask:
    15.00/16.80
  • Day's Range:
    15.10 - 16.57

ELYM Overview

Prev. Close
15.23
Day's Range
15.1-16.57
Revenue
-
Open
15.23
52 wk Range
13.65-29.69
EPS
-1.06
Volume
103,100
Market Cap
404.32M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
319,848
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
26,547,901
Next Earnings Date
Dec 01, 2021
What is your sentiment on Eliem Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Eliem Therapeutics Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellSellNeutral
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellBuy
SummaryStrong BuyBuyStrong SellStrong SellNeutral

Eliem Therapeutics Inc Company Profile

Eliem Therapeutics Inc Company Profile

Sector
Services
Employees
13

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain and ETX-155 for major depressive disorder, perimenopausal depression, and focal onset seizures. The company also develops preclinical pipeline programs, such as Kv7 Program for pain epilepsy; and Anxiolytic for the treatment of generalized anxiety. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.